| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.6 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |